Home/Filings/4/0001637761-23-000032
4//SEC Filing

Bostjancic John J. 4

Accession 0001637761-23-000032

CIK 0001637761other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 7:16 PM ET

Size

28.5 KB

Accession

0001637761-23-000032

Insider Transaction Report

Form 4
Period: 2023-01-05
Bostjancic John J.
Chief Financial Officer
Transactions
  • Disposition to Issuer

    Restricted Stock Units

    2023-01-0513,8400 total
    Common Stock (13,840 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2023-01-0562,0000 total
    Exercise: $15.68Exp: 2023-08-01Common Stock (62,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2023-01-0564,5990 total
    Exercise: $14.19Exp: 2024-01-27Common Stock (64,599 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2023-01-0569,1280 total
    Exercise: $16.86Exp: 2029-01-28Common Stock (69,128 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2023-01-0543,1630 total
    Exercise: $12.67Exp: 2030-02-28Common Stock (43,163 underlying)
  • Disposition to Issuer

    Common Stock

    2023-01-05102,5630 total
  • Disposition to Issuer

    Restricted Stock Units

    2023-01-0551,7950 total
    Common Stock (51,795 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2023-01-0517,8180 total
    Exercise: $18.24Exp: 2027-01-01Common Stock (17,818 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2023-01-0555,7460 total
    Exercise: $12.01Exp: 2028-01-01Common Stock (55,746 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2023-01-056,0890 total
    Exercise: $9.93Exp: 2028-04-23Common Stock (6,089 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2023-01-0521,7040 total
    Exercise: $15.00Exp: 2030-02-28Common Stock (21,704 underlying)
Footnotes (21)
  • [F1]Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 42,696 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
  • [F10]This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share.
  • [F11]The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
  • [F12]This option was assumed by Orthofix in the merger and replaced with an option to purchase 7,417 shares of Orthofix at a price of $43.82 per share.
  • [F13]The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
  • [F14]This option was assumed by Orthofix in the merger and replaced with an option to purchase 23,207 shares of Orthofix at a price of $28.85 per share.
  • [F15]The option fully vested and became exercisable on June 21, 2020.
  • [F16]This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,534 shares of Orthofix at a price of $23.86 per share.
  • [F17]The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
  • [F18]This option was assumed by Orthofix in the merger and replaced with an option to purchase 28,777 shares of Orthofix at a price of $40.50 per share.
  • [F19]The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock.
  • [F20]This option was assumed by Orthofix in the merger and replaced with an option to purchase 17,968 shares of Orthofix at a price of $30.44 per share.
  • [F21]This option was assumed by Orthofix in the merger and replaced with an option to purchase 9,035 shares of Orthofix at a price of $36.04 per share.
  • [F3]The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.
  • [F4]These restricted stock units were assumed by Orthofix in the merger and replaced by 5,761 Orthofix restricted stock units.
  • [F5]The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
  • [F6]These restricted stock units were assumed by Orthofix in the merger and replaced by 21,562 Orthofix restricted stock units.
  • [F7]The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
  • [F8]This option was assumed by Orthofix in the merger and replaced with an option to purchase 25,810 shares of Orthofix at a price of $37.67 per share.
  • [F9]The option vests in sixteen substantially equal quarterly installments beginning on March 31, 2016.

Issuer

SeaSpine Holdings Corp

CIK 0001637761

Entity typeother

Related Parties

1
  • filerCIK 0001644860

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 7:16 PM ET
Size
28.5 KB